share_log

HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $2 Price Target

HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $2 Price Target

HC Wainwright & Co.重申买入 NRX Pharmicals,维持2美元的目标价格
Benzinga Real-time News ·  2023/02/02 12:18

HC Wainwright & Co. analyst Vernon Bernardino reiterates NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and maintains $2 price target.

HC Wainwright & Co. 分析师弗农·贝纳迪诺重申NRX Pharmicals(纳斯达克股票代码:NRXP)的买入,并维持2美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发